DescriptionRivaroxaban is a selective inhibitor of clotting factor Xa (FXa). It does not require a cofactor (such as Anti-thrombin III) for activity. Rivaroxaban inhibits free FXa and prothrombinase activity. Rivaroxaban indirectly inhibits platelet aggregation induced by thrombin. By inhibiting FXa..
DescriptionRivaroxaban is a selective inhibitor of clotting factor Xa (FXa). It does not require a cofactor (such as Anti-thrombin III) for activity. Rivaroxaban inhibits free FXa and prothrombinase activity. Rivaroxaban indirectly inhibits platelet aggregation induced by thrombin. By inhibiting FXa..
DescriptionRivaroxaban is a selective inhibitor of clotting factor Xa (FXa). It does not require a cofactor (such as Anti-thrombin III) for activity. Rivaroxaban inhibits free FXa and prothrombinase activity. Rivaroxaban indirectly inhibits platelet aggregation induced by thrombin. By inhibiting FXa..
DescriptionRidel tablet is a preparation of Niacin. It is proven effective at lowering VLDL, LDL, total cholesterol and triglyceride levels while raising HDL levels. So Niacin has been prescriped for the treatment of cardiovascular disease particularly the hyperlipidemias.IndicationsNiacin is indica..
DescriptionRupex is a preparation of Rupatadine. Rupatadine is a new selective histamine H1 receptor and platelet-activating factor (PAF) antagonist. Rupatadine has dual mechanism of action. It acts as a long-acting, non-sedative antagonist at histaminergic H1-receptor and also antagonizes the plate..
Sabitar 100 TabletDescriptionSacubitril, a neprilysin inhibitor that inhibits neprilysin (neutral endopeptidase; NEP) via active metabolite of the prodrug sacubitril. Valsartan, a angiotensin receptor blocker that blocks the angiotensin II type-1 (AT1) receptor. The cardiovascular and renal effects ..
DescriptionSacubitril, a neprilysin inhibitor that inhibits neprilysin (neutral endopeptidase; NEP) via active metabolite of the prodrug sacubitril. Valsartan, a angiotensin receptor blocker that blocks the angiotensin II type-1 (AT1) receptor. The cardiovascular and renal effects of Sacubitril/Vals..
DescriptionSacubitril, a neprilysin inhibitor that inhibits neprilysin (neutral endopeptidase; NEP) via active metabolite of the prodrug sacubitril. Valsartan, a angiotensin receptor blocker that blocks the angiotensin II type-1 (AT1) receptor. The cardiovascular and renal effects of Sacubitril/Vals..